Results
|
481.
|
|
|
482.
|
|
|
483.
|
|
|
484.
|
|
|
485.
|
Homology modeling of lanosterol 14alpha-demethylase of Candida albicans and Aspergillus fumigatus and insights into the enzyme-substrate Interactions. [electronic resource] by
- Sheng, C
- Zhang, W
- Zhang, M
- Song, Y
- Ji, H
- Zhu, J
- Yao, J
- Yu, J
- Yang, S
- Zhou, Y
- Zhu, J
- Lu, J
Producer: 20050114
In:
Journal of biomolecular structure & dynamics vol. 22
Availability: No items available.
|
|
486.
|
|
|
487.
|
|
|
488.
|
From antidiabetic to antifungal: discovery of highly potent triazole-thiazolidinedione hybrids as novel antifungal agents. [electronic resource] by
- Wu, Shanchao
- Zhang, Yongqiang
- He, Xiaomeng
- Che, Xiaoying
- Wang, Shengzheng
- Liu, Yang
- Jiang, Yan
- Liu, Na
- Dong, Guoqiang
- Yao, Jianzhong
- Miao, Zhenyuan
- Wang, Yan
- Zhang, Wannian
- Sheng, Chunquan
Producer: 20150724
In:
ChemMedChem vol. 9
Availability: No items available.
|
|
489.
|
In vitro and in vivo studies of the antiparasitic activity of sterol 14α-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi. [electronic resource] by
- Soeiro, Maria de Nazaré Correia
- de Souza, Elen Mello
- da Silva, Cristiane França
- Batista, Denise da Gama Jaen
- Batista, Marcos Meuser
- Pavão, Beatriz Philot
- Araújo, Julianna Siciliano
- Aiub, Claudia Alessandra Fortes
- da Silva, Patrícia Bernardino
- Lionel, Jessica
- Britto, Constança
- Kim, Kwangho
- Sulikowski, Gary
- Hargrove, Tatiana Y
- Waterman, Michael R
- Lepesheva, Galina I
Producer: 20140407
In:
Antimicrobial agents and chemotherapy vol. 57
Availability: No items available.
|
|
490.
|
|
|
491.
|
|
|
492.
|
|
|
493.
|
|
|
494.
|
|
|
495.
|
|
|
496.
|
|
|
497.
|
Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives. [electronic resource] by
- Xu, Jianming
- Cao, Yongbing
- Zhang, Jun
- Yu, Shichong
- Zou, Yan
- Chai, Xiaoyun
- Wu, Qiuye
- Zhang, Dazhi
- Jiang, Yuanying
- Sun, Qingyan
Producer: 20150715
In:
European journal of medicinal chemistry vol. 46
Availability: No items available.
|
|
498.
|
CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM). [electronic resource] by
- Debnath, Anjan
- Calvet, Claudia M
- Jennings, Gareth
- Zhou, Wenxu
- Aksenov, Alexander
- Luth, Madeline R
- Abagyan, Ruben
- Nes, W David
- McKerrow, James H
- Podust, Larissa M
Producer: 20180130
In:
PLoS neglected tropical diseases vol. 11
Availability: No items available.
|
|
499.
|
|
|
500.
|
|